# US 2001/0024636 A1 · Stimulus sensitive gel with radioisotope and methods of making

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0024636 A1
- Document ID: US20010024636A1
- Status: Published application
- Kind: A1
- Application number: 09/853,507
- Filed: 2001-05-10
- Published: 2001-09-27
- Earliest claimed: 1998-04-10
- Assignees: Battelle Memorial Institute
- Inventors: Richard E. Weller; Michael A. Lind; Darrell R. Fisher; Anna Gutowska; Allison A. Campbell
- Web page: https://patentgrep.com/patent/US20010024636A1

## CPC

- A61K 51/06: Macromolecular compounds {, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules (peptides, proteins, polyamino acids A61K51/08; antibodies A61K51/10)}
- A61K 51/1213: {Semi-solid forms, gels, hydrogels, ointments, fats and waxes that are solid at room temperature}
- A61P 35/00: Antineoplastic agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention is a thermally reversible stimulus-sensitive gel or gelling copolymer radioisotope carrier that is a linear random copolymer of an [meth-]acrylamide derivative and a hydrophilic comonomer, wherein the linear random copolymer is in the form of a plurality of linear chains having a plurality of molecular weights greater than or equal to a minimum gelling molecular weight cutoff. Addition of a biodegradable backbone and/or a therapeutic agent imparts further utility. The method of the present invention for making a thermally reversible stimulus-sensitive gelling copolymer radionuclcide carrier has the steps of: (a) mixing a stimulus-sensitive reversible gelling copolymer with an aqueous solvent as a stimulus-sensitive reversible gelling solution; and (b) mixing a radioisotope with said stimulus-sensitive reversible gelling solution as said radioisotope carrier. The gel is enhanced by either combining it with a biodegradable backbone and/or a therapeutic agent in a gelling solution made by mixing the copolymer with an aqueous solvent.

## Claims

### Claim 1

A radioisotope carrier, comprising:
(a) a stimulus-sensitive gelling polymer in an aqueous solution; and
(b) an aqueous insoluble or confined radioisotope mixed with said gelling polymer as said radioisotope carrier.

### Claim 2 (depends on 1)

The radioisotope carrier as recited in claim 1, wherein said gelling polymer is selected from the group consisting of biodegradable polymer, cellulose derivative, agar, gelatin, chitosin, slowly polymerizing alginate gel, gelling copolymer, and combinations thereof.

### Claim 3 (depends on 2)

The radioisotope carrier as recited in claim 2, wherein said biodegradable polymer is selected from the group consisting of polysaccharides, polypeptides and combinations thereof.

### Claim 4 (depends on 2)

The radioisotope carrier as recited in claim 2, wherein said cellulose derivative is hydroxypropylmethyl cellulose.

### Claim 5 (depends on 2)

The radioisotope carrier as recited in claim 2, wherein said gelling copolymer, comprises:
(a) a linear random copolymer in an aqueous solvent, having
(i) an [meth-]acrylamide derivative; and
(ii) a hydrophilic comonomer;
said linear random copolymer in the form of a plurality of linear chains having a plurality of molecular weights greater than or equal to a minimum gelling molecular weight cutoff; and
(b) the aqueous solvent mixed with said hydrophilic comonomer as a reversible gelling solution.

### Claim 6 (depends on 5)

The radioisotope carrier as recited in claim 5, wherein an amount of said hydrophilic comonomer in the linear random copolymer is less than about 10 mole %.

### Claim 7 (depends on 6)

The radioisotope carrier as recited in claim 6, wherein said amount is about 2 mole %.

### Claim 8 (depends on 5)

The radioisotope carrier as recited in claim 5, wherein said [meth-]acrylamide derivative is an N,N′-alkyl substituted [meth-]acrylamides.

### Claim 9 (depends on 8)

The radioisotope carrier as recited in claim 8, wherein said N,N′-alkyl substituted [meth-]acrylamide is selected from the group consisting of N-isopropyl[meth-]acrylamide, N,N′-diethyl[meth-]acrylamide, N-[meth-]acryloylpyrrolidine, N-ethyl[meth-]acrylamide, and combinations thereof.

### Claim 10 (depends on 5)

The radioisotope carrier as recited in claim 5, wherein said hydrophilic comonomer is hydrophilic [meth-]acryl- compound.

### Claim 11 (depends on 10)

The radioisotope carrier as recited in claim 10, wherein said hydrophilic [meth-]acryl- compound is selected from the group consisting of carboxylic acid, [meth-]acrylamide, hydrophilic [meth-]acrylic acid ester, hydrophilic [meth-]acrylamide derivatives and combinations thereof.

### Claim 12 (depends on 11)

The radioisotope carrier as recited in claim 11, wherein said carboxylic acid is selected from the group consisting of acrylic acid, methacrylic acid and combinations thereof.

### Claim 13 (depends on 11)

The radioisotope carrier as recited in claim 11, wherein said hydrophilic [meth-]acrylamide derivatives are selected from the group consisting of N,N-diethyl[meth-]acrylamide, 2-[N,N-dimethylamino]ethyl[meth-]acrylamide, 2-[N,N-diethylamino]ethyl[meth-]acrylamide, or combinations thereof.

### Claim 14 (depends on 11)

The radioisotope carrier as recited in claim 11, wherein said hydrophilic [meth-]acrylic ester is selected from the group consisting of 2-[N,N-diethylamino]ethyl[meth-]acrylate, 2-[N,N-dimethylamino]ethyl[meth-]acrylate, and combinations thereof.

### Claim 15 (depends on 5)

The radioisotope carrier as recited in claim 5, wherein said aqueous solvent is selected from the group consisting of water, and aqueous salt solution.

### Claim 16 (depends on 15)

The radioisotope carrier as recited in claim 15, wherein said salt solution is a phosphate buffered saline.

### Claim 17 (depends on 16)

The radioisotope carrier as recited in claim 16, wherein an amount of said solvent is from about 70 wt % to about 99 wt %.

### Claim 18 (depends on 1)

The radioisotope carrier as recited in claim 1, wherein said radioisotope is selected from the group consisting of yttrium-90, indium-111, radium-223, actinium-225, bismuth-212, bismuth-213, scandium-47, astatine-211, rhenium-186, rhenium-188, iodine-131, iodine-124, lutetium-177, holinium-166, samarium-153, copper-64, copper-67, phosphorus-32 and combinations thereof.

### Claim 19 (depends on 1)

The radioisotope carrier as recited in claim 1, wherein said confined radioisotope is selected from the group of chelators, capsules and combinations thereof.

### Claim 20 (depends on 19)

The radioisotope carrier as recited in claim 19, wherein said chelators are selected from the group consisting of 1,4,7,10-tetraazacyclododecane-N,N′,N″,N′″-tetraacetic acid (DOTA), derivatives of DOTA, tetra-t-butyl-calix[4]arene-crown-6-dicarboxylic acid (TBBCDA), derivatives of TBBCDA, 5,11,17,23-tetra-t-butyl-25,26,27,28-tetrakis(carboxymethoxy)-calix[4]arene (TBTC), derivatives of TBTC, 5,11,17,23,29,35-hexa-t-butyl-37,38,39,40,41,42-hexakis(carboxymethoxy)-calix[6]arene (HBHC), derivatives of HBHC, diethylenetriamine-pentaacetic acid (DTPA), EDTA, derivatives of DTPA, and combinations thereof.

### Claim 21 (depends on 19)

The radioisotope carrier as recited in claim 19, wherein said capsules are selected from the group of glass beads, polymer beads and combinations thereof.

### Claim 22 (depends on 1)

The radioisotope carrier as recited in claim 1, further comprising a contrast agent.

### Claim 23 (depends on 22)

The radioisotope carrier as recited in claim 22, wherein said contrast agent is selected from the group of gamma-emitting radioisotope, ultrasound contrast enhancing agent, paramagnetic isotope, positron-emitting radioisotope and combinations thereof.

### Claim 24 (depends on 23)

The radioisotope carrier as recited in claim 23, wherein said gamma-emitting radioisotope is selected from the group of Tc-99m, In-111, Rh-186, Rh-188, Th-201, Ga-67, Y-86, Y-91, I-131, F-18, Cu-64, Cu-67, As-74, Zr-89 and combinations thereof.

### Claim 25 (depends on 23)

The radioisotope carrier as recited in claim 23, wherein said ultrasound contrast enhancing agent is a plurality of air-filled albumin-coated microspheres, human serum albumin with octofluoropropane.

### Claim 26 (depends on 23)

The radioisotope carrier as recited in claim 23, wherein said paramagnetic isotope is gadolinium.

### Claim 27 (depends on 26)

The radioisotope carrier as recited in claim 26, wherein said gadolinium is a chelate selected from the group consisting of gadolinium-DTPA, gadolinium-EDTA and combinations thereof.
